Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/21461| Title: | Nivolumab induces dynamic alterations in CD8 T-cell function and TIM-3 expression when used to treat relapsed acute myeloid leukemia after allogeneic stem cell transplantation. | Austin Authors: | Wong, Eric ;Davis, Joanne;Koldej, Rachel;Szer, Jeff;Grigg, Andrew P ;Ritchie, David | Affiliation: | Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia Medical Oncology Department of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia Australian Cancer Research Foundation Translation Research Laboratory, Sydney, Australia Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia |
Issue Date: | Jan-2020 | Date: | 2019-08-07 | Publication information: | Leukemia & lymphoma 2020; 61(1): 185-188 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/21461 | DOI: | 10.1080/10428194.2019.1648803 | Journal: | Leukemia & lymphoma | PubMed URL: | 31389281 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.